Our current issue is accessible at,
http://www.whatsBruin.com



Issue No. 2; Winter, 2000
UCLA Logo
UCLA Research
& Collaboration
"HEADS-UP!"
"What's Bruin in the Labs?"

Featuring UCLA Research News & Collaboration Opportunities

Search!
UCLA Faculty
Research Interests:


This Issue's
Featured Lab
at UCLA

California
NanoSystems
Institute

New $100 million enterprise established to leverage academic and industrial expertise in nanosystems. [more]


UCLA Conference Spotlight

Feb. 7-9, 2001; UCLA

Accelerating Change
in the Information Economy

"explore the issues and solutions - a three-day conference with business and academic leaders."
[more]


UCLA Campus
Links

  • Campus Directory
  • Research Labs, Centers and Institutes
  • Technologies Available for Licensing
  • School of Medicine's Research Page

  • About UCLA
  • UCLA Home Page

  • 
    
     
    "What's Bruin in the Labs?"

    About This
    Publication

    Welcome to UCLA Research & Collaboration HEADS-UP! — A UCLA email newsletter published for company business development executives.

    UCLA Research & Collaboration HEADS-UP! highlights UCLA research news, links and information to help facilitate:

      1) industry-university research collaborations; and,
      2) the transfer of UCLA technology for product development.

    Subscribe/un-subscribe:
    Send a "subscribe" or "unsubscribe" email to,
    oipa-news@resadmin.ucla.edu

    Published by:
    UCLA's Office of Intellectual Property Administration (OIPA)

    Contact information:
    "What's Bruin in the Labs?"
    OIPA
    10920 Wilshire Blvd, #1200
    Los Angeles, CA 90024-1406

    Please send comments and inquiries to:
    Robert Nidever, Editor
    bnidever@ucla.edu
    tel. 310-794-0558

     

      In this issue:
  • new university-industry collaboration grants - team-up for rsch $$
  • technologies/patents available for licensing
  • latest research news from our labs
  • ucla conference spotlight
  • about   "What's Bruin in the Labs?"

        

    New Grant Announcements for
    University-Industry Collaborations

    Semiconductors | Biotechnology | Advanced Technology Program

    The University of California (UC) funds several grant-matching programs to encourage research collaborations with industry. Two such programs are:
  • SMART (Semiconductor Manufacturing)
    The Semiconductor Manufacturing Alliance for Research and Training Program addresses the fast-paced research needs of the manufacturing of semiconductors and other electronic materials as a result of the rapid pace of computer chip evolution which requires redesign of manufacturing technology every few years. The focus is on next generation electronic manufacturing materials, equipment and processing, not limited to semiconductors. Research areas related to electronics manufacturing include basic sciences and a range of engineering disciplines. The Private Sponsor may generally be any California-based company or business entity engaged in producing products or services relevant to the electronics manufacturing industry. Applicants are encouraged to consult with the UC-SMART Program office during the proposal development phase if questions arise about possible overlap between the UC-MICRO program and the UC-SMART program.
    Notice of Intent to Submit Due Date: May 03, 2001
    Proposal Submission Due Date: May 15, 2001
    Program Office: (510) 642-1896
    Program Website: http://uc-smart.berkeley.edu/

  • BioSTAR (Strategic Targets for Alliances in Research)
    The Biotechnology STAR Project strives to enhance the development and transfer of research discoveries to continue to support the creation and maturation of entrepreneurial biotechnology companies in California. Priority is given to requests for seed funding for new, innovative research projects related to biotechnology (including basic sciences and biochemical engineering). Proposals for clinical trials or for medical engineering (e.g., prosthetics, etc.) generally are not appropriate. The Private Sponsor may generally be any California-based company or business entity engaged in the commercialization of biotechnology-related or biotechnology-enabling products or services.
    Notice of Intent to Submit Due Date: April 19, 2001
    Proposal Submission Due Date: May 01, 2001
    Program Office: (510) 642-5557
    Program Website: http://www-biotech.berkeley.edu
  • For additonal links to locate potential faculty research
    collaborators at UCLA, industry executives may contact,
    oipa-news@resadmin.ucla.edu
    UCLA's Contract & Grant policy information is here:   OCGA


    Latest Inventions/Technologies Available
    for Licensing from UCLA

    New inventions/patents resulting from several years of research at UCLA are now available for licensing. We spotlight several technologies below:
  • Membrane Estrogen Receptor-Directed Therapy in Breast Cancer
  • Assay to Screen Potential Drugs for HCV
  • Ultrasensitive Molecular Detection of Urinary Pathogens
  • Inflammouse—A Transgenic Indicator of Inflammation

  • Wireless Adaptive Transmission of Smoothed Video
  • Wireless Data Assistant for Relatives of ICU Patients

  • Use of Nanoparticle Chain Aggregates as Elastic Materials
  • A Rapid Solid-State Synthesis of Crystalline Gallium Nitride
  • Approx. 200 UCLA technologies are listed at:
    http://www.research.ucla.edu/tech

    "Licensing university technology for product development is a business model companies (including, Venture Capital-backed start-ups) can leverage to help minimize basic/applied research costs, and create shareholder value."

    —Rod Raynovich, Licensing Officer, Biotechnology, UCLA

    Research News
    the latest from UCLA Labs:

  • SIGA Acquires Antibiotic Technology From UCLA
  • New Molecular Imaging Center For Gene Therapy Launched at UCLA
  • The Science of Small - Will organic circuits someday overtake silicon in the race to electronic miniaturization?

  • Scientists Find Evidence of Earliest Liquid Water
  • CTI, Inc., Reports HCFA to Provide Expanded Medicare Coverage for Positron Emission Tomography (PET)
  • UCLA Internet Report
  • New UCLA Research Chairs to Study Cancers
  • UCLA-Led Geriatrics Study Researches Interleukin-6
  • UCLA Research Reveals Nicotine's Effect on Brain
  • UCLA Doctor Reports Promising Drug Helps Fight HIV

  • New Hope in New Year for Ovarian Cancer
  • BioMarin Pharmaceutical, Inc. (BMRN) And Genzyme General (GENZ) Report Publication In The New England Journal of Medicine Of Treatment With Aldurazyme(TM) In MPS-I Patients
  • Cellegy (CLGY) Expands Its Women's Sexual Dysfunction Programs

    –end–

  • Copyright 2001 Regents University of California